2000

2000-2004

Constant investments in research, in staff training, in quality and in revamping the manufacturing flows and the working spaces have turned Antibiotice into a profitable, dynamic company with a steady economic growth.

The Nystatin production line was granted the FDA authorization, which allowed the successful exportation of our active ingredient to the United States. As a result, Nystatin became the most important product exported, securing Antibiotice’s position as a top worldwide producer of Nystatin.